BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 1, 2026
See today's BioWorld
Home
» Industry warns of high cost to U.K. biopharma as Brexit vote looms
To read the full story,
subscribe
or
sign in
.
Industry warns of high cost to U.K. biopharma as Brexit vote looms
May 31, 2016
By
Nuala Moran
LONDON – As the days count down to the June 23 referendum on whether or not the U.K. should remain in the European Union (EU), the predicted impacts of either course are getting direr by the day.
BioWorld